|
|
Volumn 13, Issue 4, 1995, Pages 355-358
|
|
Phase II trial of ZD1694 (TomudexTM) in patients with advanced pancreatic cancer
a
|
|
Author keywords
pancreatic carcinoma; thymidylate synthase inhibitor; TomudexTM
|
|
Indexed keywords
QUINAZOLINE DERIVATIVE;
RALTITREXED;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ANOREXIA;
ARTICLE;
ASTHENIA;
CLINICAL ARTICLE;
CLINICAL EXAMINATION;
CLINICAL TRIAL;
DIARRHEA;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TOXICITY;
DYSPNEA;
FEMALE;
FEVER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LABORATORY TEST;
LEUKOPENIA;
LIVER FUNCTION;
MALE;
MUCOSA INFLAMMATION;
MULTICENTER STUDY;
PANCREAS ADENOCARCINOMA;
PANCREAS CANCER;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RASH;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIMETABOLITES, ANTINEOPLASTIC;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PANCREATIC NEOPLASMS;
QUINAZOLINES;
THIOPHENES;
THYMIDYLATE SYNTHASE;
|
|
EID: 0029556670
PISSN: 01676997
EISSN: 15730646
Source Type: Journal
DOI: 10.1007/BF00873144 Document Type: Article |
|
Times cited : (46)
|
|
References (7)
|
